Plasma Pen: The Non-Surgical Revolution in Skin Rejuvenation
In this in-depth blog, we'll explore everything you need to know about what it is, how it works, who it's for, benefits, potential side effects, and what to expect during and after treatment.
A Plasma Pen is an FDA-approved device used in aesthetic medicine to perform fibroblast therapy, a skin-tightening and lifting treatment. The device uses plasma energy, created by ionizing the gas in the air between its tip and the skin surface, forming a small electrical arc. This arc creates controlled micro-trauma on the skin's surface, triggering the body's natural healing process.
The result? Increased collagen and elastin production, which leads to tighter, firmer, and more youthful-looking skin over time.
The Plasma converts electrical energy into an electrostatic charge that is transmitted through a disposable probe. When the is brought close to the skin, it ionizes the oxygen and nitrogen in the air, creating a small plasma flash. This arc never touches the skin but creates tiny micro-injuries on the epidermis (outer layer), stimulating the fibroblasts in the dermis to produce new collagen and regenerate tissue.
This process: Tightens loose skin
Reduces wrinkles and fine lines
Improves skin texture and tone
Promotes natural healing
The Plasma Pen is versatile and can address a wide range of skin concerns, including: Fine lines and wrinkles
Crows' feet
Droopy eyelids (non-surgical blepharoplasty)
Forehead lines
Smile lines
Neck lines (turkey neck)
Stretch marks
Scars and acne scars
Age spots and pigmentation
The device is most commonly used on the face and neck, but it can also be used on the abdomen, knees, and other parts of the body. Benefits of Plasma Pen Treatment
No incisions, no stitches, and no general anesthesia required. It's a perfect option for people seeking an alternative to surgical lifts and tucks.
While there's some temporary redness and scabbing, the recovery is relatively short, typically 7–10 days compared to weeks for surgery.
The results develop gradually over several weeks as collagen rebuilds, giving a more natural and subtle enhancement.
With proper skin care, results can last 2–3 years or more. Maintenance treatments may be performed as needed.
Trained practitioners can precisely target problem areas without affecting surrounding tissues.
Ideal candidates for Plasma Pen treatment are individuals who: Are in good general health
Have mild to moderate skin laxity
Are non-smokers
Have realistic expectations
Are not pregnant or breastfeeding
People with darker skin tones may need to consult with their provider about the risks of hyperpigmentation or hypopigmentation, as plasma treatments can occasionally affect melanin.
Your provider will assess your skin, discuss your goals, and determine if the Plasma Pen is the right treatment for you.
Topical numbing cream is applied to ensure comfort during the procedure. This is typically left on for 30–60 minutes.
The Plasma Pen is moved across targeted areas, creating a series of tiny dots (carbon crusts) where the plasma energy comes into contact with the skin. The session typically lasts 30 to 90 minutes, depending on the treatment area.
You'll receive detailed aftercare instructions. Swelling and redness are common for the first few days, followed by the formation of small scabs. These crusts naturally fall off within a week. Do not pick at the scabs. Allow them to fall off naturally to avoid scarring.
Allow them to fall off naturally to avoid scarring. Avoid direct sun exposure for at least 2 weeks. Use SPF 50+ daily.
for at least 2 weeks. Use SPF 50+ daily. Skip makeup until your provider gives you the all-clear.
until your provider gives you the all-clear. Use only recommended products to soothe and hydrate the skin (usually a healing balm or cream).
to soothe and hydrate the skin (usually a healing balm or cream). Avoid hot showers, saunas, and excessive sweating during the first 7–10 days.
Initial tightening may be noticeable within a week, but full results typically develop over 8 to 12 weeks as collagen regenerates. Many patients require only one session, while others may benefit from two or more treatments spaced several weeks apart.
When performed by a certified and trained professional, it is considered safe. However, like any aesthetic procedure, there are potential risks: Swelling and redness
Scabbing or crusting
Hyperpigmentation or hypopigmentation
Infection (rare)
Prolonged healing occurs if aftercare is not followed
Always choose a reputable provider with experience using the Plasma Pen device. Treatment Invasiveness Downtime Results Duration Cost Plasma Pen Non-surgical 7–10 days 2–3 years Moderate Botox Non-surgical Minimal 3–6 months Low to moderate Microneedling Non-surgical 1–3 days 6–12 months Low Surgical Facelift Invasive 3–4 weeks 5–10 years High
The Plasma Pen bridges the gap between injectables and surgical procedures, offering a cost-effective alternative with long-lasting results. Conclusion: Is the Plasma Pen Right for You?
If you're looking for a powerful, non-invasive way to rejuvenate your skin, tighten problem areas, and reduce signs of aging, the Plasma Pen could be the ideal solution. With its ability to stimulate collagen naturally, this treatment provides long-term benefits without the risk and downtime of traditional surgery.
Whether you're considering treatment for fine lines around the eyes, loose skin on the neck, or acne scars, always consult a licensed aesthetic provider for a personalized recommendation. Further, for more, you can donate freedom plasma
Ready to reveal younger, firmer skin? The Plasma Pen might be your secret weapon.
TIME BUSINESS NEWS
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
2 hours ago
- Business Wire
Single Pass Inc. Launches Global Post-Market Evaluation of the Biopsy Tract Closure Device
LAKE FOREST, Calif.--(BUSINESS WIRE)--Single Pass Inc., a medical technology innovator focused on improving procedural safety in biopsy care, today announced the launch and first enrollment in B-S.A.F.E. (Biopsy with SinglePass: Assessing Fast & Effective Tract Closure) – a global, post-FDA market evaluation to generate real-world evidence of the SinglePass™ electrocautery biopsy closure device. I use SinglePass on every visceral biopsy for both tumor and parenchyma, including kidney and liver! This innovative device efficiently seals biopsy channels, reducing bleeding risks and improving patient safety across all my biopsy procedures. Share Despite the millions of solid organ percutaneous biopsies performed successfully each year, unintended bleeding post-procedure is a real risk requiring additional procedures, longer hospital stays, and increased costs. And in rare instances, the complications can be devastating. The SinglePass device is designed to cauterize the biopsy tract immediately after tissue extraction, offering a novel approach to reduce bleeding complications, enhance procedural efficiency, and optimize patient observation time. 'Single Pass's global post-market evaluation - B-S.A.F.E. - reflects our commitment to innovation backed by evidence,' said John Zehren, CEO of Single Pass Inc. 'We're honored to work alongside frontline clinicians to validate real-world safety, usability, and performance, bringing an innovative solution for patients undergoing biopsy procedures.' B-S.A.F.E. is a multicenter post-market device evaluation that will assess reduction in post-biopsy bleeding and complications, post-biopsy observation time and workflow optimization. 'The SinglePass device represents a transformational advancement in the world of core needle biopsy,' said Dr. Alexander Misono, MD, MBA, RPVI, Chief of Interventional Radiology at Hoag Hospital Irvine in Irvine, CA. 'With the ability of SinglePass to provide immediate and reliable tract closure, we are already witnessing an inevitable shift in the way we manage bleeding risk and patient recovery. I'm proud to contribute to this evaluation and help drive the future standard of care.' "I use SinglePass on every visceral biopsy for both tumor and parenchyma, including kidney and liver!' remarked Dr. Francis Kang, Clinical Chief of Interventional Radiology at Robert Wood Johnson University Hospital in New Brunswick, NJ. 'This innovative device efficiently seals biopsy channels, significantly reducing bleeding risks and improving patient safety across all my biopsy procedures." For more information, visit About Single Pass Inc. Single Pass Inc. is a privately held medical device company dedicated to enhancing safety and workflow efficiency in image-guided biopsy procedures. Its flagship device, the SinglePass Electrocautery Biopsy Closure Device, enables clinicians to cauterize the biopsy tract in a single step, potentially improving patient outcomes and reducing procedural complexity. The company is headquartered in Lake Forest, California.
Newsweek
3 hours ago
- Newsweek
Blueberry Recall Update as FDA Issues Most Severe Risk Level
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A recall of hundreds of boxes of blueberries due to possible contamination with Listeria monocytogenes has now been issued the highest risk warning by the U.S. Food and Drug Administration (FDA). Alma Pak International LLC, based in Georgia, issued a voluntary recall for 400 boxes of its organic blueberries on June 9. The FDA subsequently issued its Class 1 risk classification on July 1. Newsweek contacted Alma Pak International LLC for comment by email outside of regular working hours. Stock image. Alma Pak International LLC issued a voluntary recall for 400 boxes of its organic blueberries on June 9. Stock image. Alma Pak International LLC issued a voluntary recall for 400 boxes of its organic blueberries on June 9. Sina Schuldt/picture-alliance/dpa/AP Images Why It Matters A Class I risk classification represents "a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death," according to the FDA. Listeria infection, or listeriosis, may lead to a range of symptoms in infected individuals. For those experiencing less severe infections, symptoms include fever, muscle aches, nausea, vomiting and diarrhea, which often last between one and three days, the FDA said. For more severe and potentially life-threatening infections, symptoms may include headaches, stiff neck, confusion, loss of balance and convulsions. Severe infections are particularly dangerous for newborns, adults over age 65 and those with weakened immune systems. What To Know A total of 400 boxes of the firm's organic blueberries are impacted by the recall. Each box weighs 30 lbs. The blueberries were shipped to one customer in North Carolina, and can be identified by the Lot numbers: 13325 G1060 / 13325 G 1096. The recall was initiated after the firm obtained positive test results for Listeria monocytogenes during routine testing of the product. What People Are Saying Haley F. Oliver, a professor of food science at Purdue University, told Newsweek previously: "Listeria monocytogenes is a common microorganism that can be found in the natural environment, for example in soil. There are many factors that determine if someone gets listeriosis — a listeria infection. In most instances, an immunocompromised person, so young, old, pregnant or otherwise immunocompromised, must eat contaminated food. The number of bacteria resulting in infection and the amount of time before illness varies considerably. Symptoms vary among people but can include fever, flu-like symptoms, headache, stiff neck, confusion and loss of balance." Mary O'Riordan, a professor of microbiology and immunology at the University of Michigan Medical School, told Newsweek previously: "Listeria has an unusual capacity to grow at refrigerated temperatures. Although the bacterium can contaminate many types of food, cheeses or deli meats that are kept in cold storage for long periods in stores or at home, are a place where listeria can keep growing. "Early symptoms of listeria infection look similar to other common foodborne infections, including fever, diarrhea and vomiting, so it's often not diagnosed right away. Unfortunately, sometimes listeria can spread into the brain and cause more serious illness, like meningitis. In those cases, if people experience headache, stiff neck or confusion, they should seek urgent medical attention." The FDA said on its website: "Pregnant women and their unborn or newborn baby, adults over the age of 65, and those with weakened immune systems, are all considered to be high-risk groups that are susceptible to the serious and adverse effects of listeriosis." What Happens Next The recall is listed as ongoing, according to the FDA. The agency advises anyone who suspects that they have developed symptoms resembling a listeriosis infection to contact their healthcare provider immediately.
The Onion
3 hours ago
- The Onion
FDA Recalls 3 Oranges To Prove They Can Juggle
SILVER SPRING, MD—Issuing a public warning for Americans to watch or they might miss out, the U.S. Food and Drug Administration reportedly recalled three navel oranges Wednesday to prove that they could juggle. 'Toss 'em here,' said spokesperson John Lavietes, adding that American consumers who had recently purchased navel, Valencia, or blood oranges should not consume the citrus fruits but instead bring three of them to the nearest FDA office so the federal agency could show them something. 'It's been a while, but we can definitely do it. Organic, GMO, even a mandarin or tangelo should be brought to this lectern immediately. Come on, any region or distributor works. They have to be firm, though. If they're not firm, we can't do it.' At press time, the FDA had recalled one more orange to replace the one that had rolled under the table.
